ANNAPOLIS, MD—Governor Larry Hogan today announced a new Maryland Cancer Moonshot Initiative to expand and accelerate cancer detection, screening, prevention, treatment, and research in the state. The state is committing $216 million in investments as a down payment to jumpstart this far-reaching initiative to save lives, including the first ever comprehensive cancer center in Prince George’s County.
FREDERICK, Md. — The first company to make rapid take-home COVID-19 tests is now making them in Maryland.
A few months ago, it was nearly impossible to find an at-home COVID-19 test in stores across Maryland. Now, store shelves are stocked with boxes of test kits from different brands.
But it's not just about COVID-19 at Ellume's manufacturing plant In Frederick. The large manufacturing facility was built to support the federal government's response to the current pandemic and future ones.
Hailed as a medical breakthrough a year ago, Ellume's COVID-19 at-home test kits are rolling off a state-of-the-art assembly line in Frederick, which held its grand opening Thursday.
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). We are seeking a Life SciencesBusiness Strategist to join our team remotely.
The right candidate will be an energetic and continuous learner who is passionate about accelerating the adoption of new technologies to improve lives. The position is geared toward an early-career scientist (generally in their first 5-7 years after receiving their PhD) who wants to engage with the biohealth industry in new ways.
The NasaClip device provides simple and effective nosebleed rescue at home or anywhere, using hands-free, external nasal compression with intranasal sponges that medicine can be added to – helping to stop nosebleeds fast.
Individuals from diverse backgrounds can provide unique and valuable contributions in the research and development of life science innovations that prevent disease, prolong life, and promote health. However, certain groups, such as women and individuals from racial/ethnic minoritized groups, remain underrepresented in the U.S. biomedical sciences and in life science entrepreneurship.
A new 500,000 square-foot life science campus is being planned for Frederick County.
With two 100,000 square-foot research and development labs; two additional 145,000 square-foot production buildings; co-working space; conference rooms; and more, The Labs at Jefferson Tech Park will provide in demand, state-of-the-art space for life science companies looking to locate along the I-270 corridor.
The campus – which aims to be the “premier biodiscovery campus” in the county – is also expected to host numerous fitness and walking trails, outdoor green space, a cafe, and plenty of parking.
Today, I am pleased to introduce the inaugural cohort of the NIH 21st Century Scholars Program—a new COSWD-sponsored initiative to promote awareness of the science of scientific workforce diversity. Six mentors and 13 cohort engagement participants from the NIH extramural scientific workforce were selected; together, they will build a vibrant, self-reinforcing culture of mentoring and support with a focus on diversity at the NIH.
Please join the inaugural webcast “Tell Me Something I Don’t Know,” hosted by Children’s National Hospital (CNH) Innovation Ventures and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). In this episode, we learn about the process of selecting novel technologies for implementation at CNH. Jennifer Yin, MSN, RN, CVAHP, hospital’s Value Analysis Clinical Program Manager, will engage in a fireside chat with Francesca Joseph, MD, FAAP, Pediatrician at CNH and co-Investigator of NCC-PDI. Jennifer and Francesca will provide a general understanding of the Value Analysis process and highlight topics most relevant to medical device innovators.
A Brisbane-based company that has targeted the premium end of the COVID home diagnosis boom has officially opened its 20,000-square-metre facility in the US, but its founder is now nervous about a potential flu pandemic as "vaccine weariness" sets in.
Ellume founder and CEO Sean Parsons tells Business News Australia the opening of the facility in Frederick, Maryland moves "moves us into pretty rarefied air" of companies that have massive capability for manufacturing tests for COVID and other viruses, at around 500,000 per day.
One of the most impactful moments I’ve witnessed working in the life sciences sector happened on the campus of Edwards Lifesciences last year.
Just months after having surgery, a patient met face to face with the team behind her heart valve replacement. She got to thank the people who built and inspected the very device now helping her heart function properly. They hugged, they clapped. For many of the Edwards team, it was the first time they were able to meet a patient whose life they changed.
It’s not often we see these moments up close – the ones where it’s so clear why we do what we do in the life sciences. This is what we do—deliver innovative solutions for healthier lives.
Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022.
European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling €660M. Neither month matched the biotech investment highs of December 2021.
